We are developing next generation antibodies into transformative cancer therapies that improve patients’ lives.

We’re leveraging our understanding of the tumor microenvironment to develop product candidates that are designed to optimize critical components required for an effective anti-tumor response to cancer

Our platforms enable us to identify therapeutic leads with exceptional speed and diversity

We’re advancing a robust portfolio of therapeutic candidates bridging the innate and adaptive immune system

Learn more about our clinical trials